Bellecapital International Ltd. Bristol Myers Squibb CO Transaction History

Bellecapital International Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 24, 2020	SELL	$46.4 - $67.43 $424,652 - $617,119	-9,152 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $203,188 - $265,040	4,129 Added 82.2%	9,152 $587,000
Q2 2019 Jul 22, 2019	SELL	$44.62 - $49.34 $660,822 - $730,725	-14,810 Reduced 74.67%	5,023 $228,000
Q1 2019 Apr 23, 2019	BUY	$45.12 - $53.8 $691,328 - $824,323	15,322 Added 339.66%	19,833 $946,000
Q4 2018 Feb 07, 2019	BUY	$48.76 - $63.23 $219,956 - $285,230	4,511 New	4,511 $234,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Bellecapital International Ltd., based on Form 13F filings with the SEC.

Stay updated on Bellecapital International Ltd. with notifications on news.